NPC 12626

Drug Profile

NPC 12626

Latest Information Update: 30 Jan 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Scios
  • Class Amino acids; Antiepileptic drugs; Neuroprotectants; Small molecules
  • Mechanism of Action Excitatory amino acid antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Epilepsy; Huntington's disease

Most Recent Events

  • 30 Jan 1997 Discontinued-Unspecified Phase in Huntington's disease in USA (unspecified route)
  • 14 Dec 1994 Discontinued-Unspecified Phase in Epilepsy in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top